{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:40Z","timestamp":1786119940133,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate (1) levels of the host-defense\/antimicrobial peptide LL-37 in patients with trauma and hemorrhagic shock (HS) and (2) the effects of a synthetic host-defense peptide; Pep19-4LF on multiple organ failure (MOF) associated with HS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>HS is a common cause of death in severely injured patients. There is no specific therapy that reduces HS-associated MOF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>(1) LL-37 was measured in 47 trauma\/HS patients admitted to an urban major trauma center. (2) Male Wistar rats were submitted to HS (90\u200amin, target mean arterial pressure: 27\u201332\u200amm Hg) or sham operation. Rats were treated with Pep19-4LF [66 (n = 8) or 333\u200a\u03bcg\/kg\u200a\u00b7\u200ah (n = 8)] or vehicle (n = 12) for 4 hours following resuscitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Plasma LL-37 was 12-fold higher in patients with trauma\/HS compared to healthy volunteers. HS rats treated with Pep19-4LF (high dose) had a higher mean arterial pressure at the end of the 4-hour resuscitation period (79\u200a\u00b1\u200a4 vs 54\u200a\u00b1\u200a5\u200amm Hg) and less renal dysfunction, liver injury, and lung inflammation than HS rats treated with vehicle. Pep19-4LF enhanced (kidney\/liver) the phosphorylation of (1) protein kinase B and (2) endothelial nitric oxide synthase. Pep19-4LF attenuated the HS-induced (1) translocation of p65 from cytosol to nucleus, (2) phosphorylation of I\u03baB kinase on Ser\n                      <jats:sup>176\/180<\/jats:sup>\n                      , and (3) phosphorylation of I\u03baB\u03b1 on Ser\n                      <jats:sup>32\/36<\/jats:sup>\n                      resulting in inhibition of nuclear factor kappa B and formation of proinflammatory cytokines. Pep19-4LF prevented the release of tumor necrosis factor alpha caused by heparan sulfate in human mononuclear cells by binding to this damage-associated molecular pattern.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Trauma-associated HS results in release of LL-37. The synthetic host-defense\/antimicrobial peptide Pep19-4LF attenuates the organ injury\/dysfunction associated with HS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000002186","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T10:05:17Z","timestamp":1489226717000},"page":"348-356","source":"Crossref","is-referenced-by-count":17,"title":["Novel Synthetic, Host-defense Peptide Protects Against Organ Injury\/Dysfunction in a Rat Model of Severe Hemorrhagic Shock"],"prefix":"10.1097","volume":"268","author":[{"given":"Noriaki","family":"Yamada","sequence":"first","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas B.","family":"Martin","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"},{"name":"Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Zechendorf","sequence":"additional","affiliation":[{"name":"Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth S. D.","family":"Purvis","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Chiazza","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Varrone","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Collino","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Barts Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Heinbockel","sequence":"additional","affiliation":[{"name":"Division of Biophysics, Forschungszentrum Borstel, Borstel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gutsmann","sequence":"additional","affiliation":[{"name":"Division of Biophysics, Forschungszentrum Borstel, Borstel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilmar","family":"Correa","sequence":"additional","affiliation":[{"name":"Division of Biophysics, Forschungszentrum Borstel, Borstel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Brandenburg","sequence":"additional","affiliation":[{"name":"Division of Biophysics, Forschungszentrum Borstel, Borstel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Marx","sequence":"additional","affiliation":[{"name":"Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schuerholz","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Intensive Care, University of Rostock, Rostock, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Brohi","sequence":"additional","affiliation":[{"name":"Barts Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Thiemermann","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230923","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/TA.0000000000000147","article-title":"Temporal trends of postinjury multiple-organ failure: still resource intensive, morbid, and lethal","volume":"76","author":"Sauaia","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"R3-20230923","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(14)60687-5","article-title":"The systemic immune response to trauma: an overview of pathophysiology and treatment","volume":"384","author":"Lord","year":"2014","journal-title":"Lancet"},{"key":"R4-20230923","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0952-7915(99)80005-3","article-title":"Antimicrobial peptides in mammalian and insect host defence","volume":"11","author":"Lehrer","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"R5-20230923","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2009.12.004","article-title":"Antimicrobial peptides: general overview and clinical implications in human health and disease","volume":"135","author":"Guani-Guerra","year":"2010","journal-title":"Clin Immunol"},{"key":"R6-20230923","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fimmu.2015.00404","article-title":"Antimicrobial peptides in human sepsis","volume":"6","author":"Martin","year":"2015","journal-title":"Front Immunol"},{"key":"R7-20230923","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/cc11220","article-title":"Antimicrobial peptides and their potential application in inflammation and sepsis","volume":"16","author":"Schuerholz","year":"2012","journal-title":"Crit Care"},{"key":"R8-20230923","doi-asserted-by":"crossref","first-page":"e85765","DOI":"10.1371\/journal.pone.0085765","article-title":"Antimicrobial cathelicidin peptide LL-37 inhibits the LPS\/ATP-induced pyroptosis of macrophages by dual mechanism","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"R9-20230923","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"key":"R10-20230923","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1517\/14656566.7.6.653","article-title":"Antimicrobial peptides: therapeutic potential","volume":"7","author":"Zhang","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"R11-20230923","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1128\/AAC.00534-10","article-title":"New antiseptic peptides to protect against endotoxin-mediated shock","volume":"54","author":"Gutsmann","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-20230923","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1038\/srep14292","article-title":"Lipoproteins\/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides","volume":"5","author":"De Tejada","year":"2015","journal-title":"Sci Rep"},{"key":"R13-20230923","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/cc11920","article-title":"The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study","volume":"17","author":"Schuerholz","year":"2013","journal-title":"Crit Care"},{"key":"R14-20230923","doi-asserted-by":"crossref","first-page":"e0127584","DOI":"10.1371\/journal.pone.0127584","article-title":"Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum","volume":"10","author":"Martin","year":"2015","journal-title":"PLoS One"},{"key":"R15-20230923","doi-asserted-by":"crossref","first-page":"e0143583","DOI":"10.1371\/journal.pone.0143583","article-title":"The synthetic antimicrobial peptide 19-2.5 interacts with heparanase and heparan sulfate in murine and human epsis","volume":"10","author":"Martin","year":"2015","journal-title":"PLoS One"},{"key":"R16-20230923","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/SLA.0000000000001664","article-title":"Artesunate protects against the organ injury and dysfunction induced by severe hemorrhage and resuscitation","volume":"265","author":"Sordi","year":"2017","journal-title":"Ann Surg"},{"key":"R17-20230923","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2119\/molmed.2015.00049","article-title":"Inhibition of ikappaB kinase attenuates the organ injury and dysfunction associated with hemorrhagic shock","volume":"21","author":"Sordi","year":"2015","journal-title":"Mol Med"},{"key":"R18-20230923","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12967-015-0481-5","article-title":"Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients","volume":"13","author":"Rahbar","year":"2015","journal-title":"J Transl Med"},{"key":"R19-20230923","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.injury.2009.05.024","article-title":"Postinjury multiple organ failure","volume":"40","author":"Dewar","year":"2009","journal-title":"Injury"},{"key":"R20-20230923","first-page":"575","article-title":"Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (review)","volume":"4","author":"Jarrer","year":"1999","journal-title":"Int J Mol Med"},{"key":"R21-20230923","doi-asserted-by":"crossref","first-page":"e0122096","DOI":"10.1371\/journal.pone.0122096","article-title":"\u2019Preconditioning\u2019 with low dose lipopolysaccharide aggravates the organ injury\/dysfunction caused by hemorrhagic shock in rats","volume":"10","author":"Sordi","year":"2015","journal-title":"PLoS One"},{"key":"R22-20230923","first-page":"H2119","article-title":"Significance of TNF in hemorrhage-related hemodynamic alterations, organ injury, and mortality in rats","volume":"272","author":"Bahrami","year":"1997","journal-title":"Am J Physiol"},{"key":"R23-20230923","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/SHK.0000000000000211","article-title":"Delayed neutralization of interleukin 6 reduces organ injury, selectively suppresses inflammatory mediator, and partially normalizes immune dysfunction following trauma and hemorrhagic shock","volume":"42","author":"Zhang","year":"2014","journal-title":"Shock"},{"key":"R24-20230923","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","article-title":"PAMPs and DAMPs: signal 0s that spur autophagy and immunity","volume":"249","author":"Tang","year":"2012","journal-title":"Immunol Rev"},{"key":"R25-20230923","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fimmu.2012.00287","article-title":"The danger theory: 20 years later","volume":"3","author":"Pradeu","year":"2012","journal-title":"Front Immunol"},{"key":"R26-20230923","doi-asserted-by":"crossref","first-page":"3758278","DOI":"10.1155\/2016\/3758278","article-title":"The endothelial glycocalyx: new diagnostic and therapeutic approaches in sepsis","volume":"2016","author":"Martin","year":"2016","journal-title":"Biomed Res Int"},{"key":"R27-20230923","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0092-8674(00)81698-0","article-title":"Structure of an IkappaBalpha\/NF-kappaB complex","volume":"95","author":"Jacobs","year":"1998","journal-title":"Cell"},{"issue":"(suppl 1)","key":"R28-20230923","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/00003246-200201001-00003","article-title":"The IKK\/NF-kappaB pathway","volume":"30","author":"Senftleben","year":"2002","journal-title":"Crit Care Med"},{"key":"R29-20230923","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"R30-20230923","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/TA.0000000000000229","article-title":"Improvement of ventilation-induced lung injury in a rodent model by inhibition of inhibitory kB kinase","volume":"76","author":"Shu","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"R31-20230923","first-page":"1021","article-title":"Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the beta-common receptor","volume":"6","author":"Khan","year":"2013","journal-title":"Dis Model Mech"},{"key":"R32-20230923","first-page":"1031","article-title":"Inhibition of IkappaB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse","volume":"6","author":"Coldewey","year":"2013","journal-title":"Dis Model Mech"},{"key":"R33-20230923","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.CIR.0000127954.98131.23","article-title":"Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia\/reperfusion injury","volume":"109","author":"Cai","year":"2004","journal-title":"Circulation"},{"key":"R34-20230923","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.resuscitation.2009.03.001","article-title":"Exogenous nitric oxide induces protection during hemorrhagic shock","volume":"80","author":"Cabrales","year":"2009","journal-title":"Resuscitation"},{"key":"R35-20230923","first-page":"701","article-title":"Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock","volume":"6","author":"Nandra","year":"2013","journal-title":"Dis Model Mech"},{"key":"R36-20230923","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00068-015-0504-1","article-title":"Impact of haemorrhagic shock intensity on the dynamic of alarmins release in porcine poly-trauma animal model","volume":"42","author":"Horst","year":"2016","journal-title":"Eur J Trauma Emerg Surg"},{"key":"R37-20230923","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1681\/ASN.2009101048","article-title":"HMGB1 contributes to kidney ischemia reperfusion injury","volume":"21","author":"Wu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R38-20230923","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.4049\/jimmunol.1402490","article-title":"Intestinal epithelial TLR-4 activation is required for the development of acute lung injury after trauma\/hemorrhagic shock via the release of HMGB1 from the gut","volume":"194","author":"Sodhi","year":"2015","journal-title":"J Immunol"},{"key":"R39-20230923","doi-asserted-by":"crossref","first-page":"H1468","DOI":"10.1152\/ajpheart.00006.2016","article-title":"Plasma syndecan-1 and heparan sulfate correlate with microvascular glycocalyx degradation in hemorrhaged rats after different resuscitation fluids","volume":"310","author":"Torres Filho","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R40-20230923","doi-asserted-by":"crossref","first-page":"R1538","DOI":"10.1152\/ajpregu.00272.2007","article-title":"Systemic inflammation and remote organ injury following trauma require HMGB1","volume":"293","author":"Levy","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000658-201808000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:28:23Z","timestamp":1786044503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000658-201808000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000002186","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}